Li, Jie http://orcid.org/0000-0003-0121-1291
Augustynovich, Ashley E.
Gurnani, Payal K.
Fink, James B.
Article History
Received: 30 June 2021
Accepted: 16 August 2021
First Online: 21 August 2021
Declarations
:
: This study was approved by Institutional Review Board at Rush University Medical Center, Chicago, IL (Approval No. 19073005-IRB01). Written consents were not required since this was a retrospective, observational cohort study.
: Not applicable.
: Dr. Li declares to receive research funding from Fisher & Paykel Healthcare Ltd, Aerogen Ltd, and Rice Foundation and lecture honorarium from AARC and Fisher & Paykel Healthcare Ltd outside the submitted work. Dr. Fink is Chief Science Officer for Aerogen Pharma Corp. The companies had no role in the study design, data collection, analysis, preparation of the manuscript, or the decision to publish the findings. Other authors have no conflicts to disclose.